Impact of comorbidities on outcomes of elderly patients with diffuse large B-cell lymphoma
Author:
Affiliation:
1. Department of Hematology and Medical Oncology; Taussig Cancer Institute, Cleveland Clinic; 9500 Euclid Ave, Cleveland, Ohio 44195
2. Quantitative Health Sciences, Cleveland Clinic; Cleveland Ohio 44195 USA
Publisher
Wiley
Subject
Hematology
Reference22 articles.
1. Clinical approach to diffuse large B cell lymphoma;Caimi;Blood Rev.,2016
2. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP;Sehn;Blood.,2007
3. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era;Zhou;Blood.,2014
4. Cancer and Leukemia Group B; Southwest Oncology Group.: Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI);Advani;Br J Haematol.,2010
5. Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy;Jamil;Expert Rev Hematol.,2016
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review;Critical Reviews in Oncology/Hematology;2024-04
2. Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma;Hematological Oncology;2024-01
3. Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial;Blood Advances;2023-12-28
4. The Prognostic Impact of Comorbidity, Nutritional and Performance Status on Patients with Diffuse Large B Cell Lymphoma;Nigerian Journal of Clinical Practice;2023-10
5. The Relative Dose Intensity Changes during Cycles of Standard Regimens in Patients with Diffuse Large B-Cell Lymphoma;Cancers;2023-09-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3